Scott M. Coiante

Insider Reports History

Entity
Individual
Location
101 Poor Farm Road 3 Rd Floor, Princeton, New Jersey
Signature
/s/ Geoffrey P. Gilmore Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott M. Coiante:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. SVP, Chief Financial Officer Common Stock 145 K $534 K $3.68 Jul 28, 2022 Direct
AGILE THERAPEUTICS INC Chief Financial Officer Common Stock 20.1 K $17.1 K $0.85 Oct 3, 2023 Direct
Aprea Therapeutics, Inc. SVP, Chief Financial Officer Stock Option (right to Buy) 89.2 K Jul 28, 2022 Direct

Insider Reports Filed by Scott M. Coiante

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AGRX AGILE THERAPEUTICS INC Oct 3, 2023 1 $0 4 Oct 4, 2023 Chief Financial Officer
AGRX AGILE THERAPEUTICS INC Aug 16, 2023 0 $0 3 Aug 25, 2023 Chief Financial Officer
APRE Aprea Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 SVP, Chief Financial Officer
APRE Aprea Therapeutics, Inc. Jun 3, 2022 1 -$28.4 K 4 Jun 7, 2022 SVP, Chief Financial Officer, Director
APRE Aprea Therapeutics, Inc. Mar 10, 2022 2 $0 4 Mar 14, 2022 SVP, Chief Financial Officer, Director
APRE Aprea Therapeutics, Inc. Feb 25, 2022 1 -$25.8 K 4 Mar 1, 2022 SVP, Chief Financial Officer
APRE Aprea Therapeutics, Inc. Aug 25, 2021 1 -$30 K 4 Aug 27, 2021 SVP, Chief Financial Officer